Innovations in Biomedical Technology

NeuroCytonix, Inc.

Brain Regenerative Technology

In 2017, Dr. Trujillo established NeuroCytonix, Inc., a biomedical technology company after years of research and development in neural tissue engineering technology. The technology developed is a biomedical innovation designed to stimulate brain regeneration, restoring the structure of a damaged nervous system. The company is headquartered near the US National Institutes of Health (NIH) in Rockville, Maryland, USA.

NeuroCytonix’s brain regenerative technology is a potential solution for the treatment of neurological disorders. Neurological disorders are diseases that affect the nervous system. The nervous system is known to be complex and has a network of nerve cells called neurons. Neurons facilitate communication between the brain and the rest of the body. When the nervous system is damaged it affects the brain’s ability to communicate with the rest of the body. Neurocytonix’s technology uses safe, low-spectrum radio frequencies to generate instantaneous electromagnetic fields to increase the functionality of non-functioning or damaged nerve cells. It is different from traditional approaches to medicine and surgery. Through this technology, Dr. Trujillo intends to introduce a novel approach to treating non-progressive neurological diseases.

The protocols developed by Dr. Trujillo have paved the way for potential treatments for incurable neurological disorders such as cerebral palsy, stroke, traumatic brain injuries (TBI) including sports concussions, and neurological complications associated with viral infections such as COVID-19. Clinical trials and research are presently conducted at NeuroCytonix’s FDA-compliant Clinical Research Center in Monterrey, Mexico. Dr. Trujillo and his team have completed the first FDA-controlled clinical trial for cerebral palsy. To know more about the clinical trial, please check the full description on

Neurological disorders affect millions globally. Finding ways to cope with these disabilities is a major challenge for patients and their families. With NeuroCytonix, Dr. Trujillo aims to bring hope to people suffering from incurable neurological disorders. Click here to learn more about NeuroCytonix, Inc.